Operationalizing compensation over time in neurodegenerative disease.
Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, UK.
Sarah
S
Gregory
Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa, City, IA, USA.|Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
Jeffrey D
JD
Long
Albert-Ludwigs-University Freiburg, University Medical Center, Division Freiburg Brain Imaging, Freiburg, Germany.|Albert-Ludwigs-University Freiburg, University Medical Center, Department of Psychiatry and Psychotherapy, Freiburg, Germany.|University Hospital for Old Age Psychiatry, Murtenstrasse 21, 3010 Bern, Switzerland.
Stefan
S
Klöppel
Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, UK.|Department of Electronic Engineering, N.E.D University of Engineering and Technology, Karachi, Pakistan.
Adeel
A
Razi
Albert-Ludwigs-University Freiburg, University Medical Center, Division Freiburg Brain Imaging, Freiburg, Germany.|Albert-Ludwigs-University Freiburg, University Medical Center, Department of Psychiatry and Psychotherapy, Freiburg, Germany.|Albert-Ludwigs-University Freiburg, Department of Psychology, Laboratory for Biological and Personality Psychology, Freiburg, Germany.
Elisa
E
Scheller
Albert-Ludwigs-University Freiburg, University Medical Center, Division Freiburg Brain Imaging, Freiburg, Germany.|Albert-Ludwigs-University Freiburg, University Medical Center, Department of Psychiatry and Psychotherapy, Freiburg, Germany.|Albert-Ludwigs-University Freiburg, Department of Psychology, Laboratory for Biological and Personality Psychology, Freiburg, Germany.
Lora
L
Minkova
Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK.
Marina
M
Papoutsi
Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa, City, IA, USA.
James A
JA
Mills
APHP Department of Genetics, Groupe Hospitalier Pitié-Salpêtrière, and Institut du Cerveau et de la Moelle, INSERM U1127, CNRS UMR7225, UPMC Université Paris VI UMR_S1127, Paris France.
Alexandra
A
Durr
Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Canada.
Blair R
BR
Leavitt
Leiden University Medical Center, Department of Neurology, Leiden, The Netherlands.
Raymund A C
RAC
Roos
School of Psychological Sciences and Institute of Clinical and Cognitive Neuroscience, Monash University, Melbourne, Australia.
Julie C
JC
Stout
Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK.
Rachael I
RI
Scahill
Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa, City, IA, USA.|Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
Douglas R
DR
Langbehn
Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK.
Sarah J
SJ
Tabrizi
Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, UK.|Institute of Cognitive Neuroscience, University College London, London, UK.
Geraint
G
Rees
D006801:Humans; D006816:Huntington Disease / Q000503:physiopathology*; D008962:Models, Theoretical; D019636:Neurodegenerative Diseases / Q000503:physiopathology*
Huntington’s disease; MRI; compensation; longitudinal analysis; neurodegeneration